Glenmark Pharmaceuticals has informed that it attached media release on January 27,2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg’.
The above information is a part of company’s filings submitted to BSE.